News
on
|
Research Feature
INTRODUCTION: April P. Carson, Ph.D., was recently named director of the Jackson Heart Study (JHS), the largest and longest running study of cardiovascular disease in African Americans. With this appointment, Dr. Carson becomes the first woman to be named director of the study, which is now in its 22nd year. In addition to holding the title of JHS...
|
Media Availability
For Rare Disease Day 2022, NHLBI experts available to discuss rare heart, lung, and blood conditions
WHAT: To raise awareness about Rare Disease Day on February 28, researchers from the National Heart, Lung, and Blood Institute (NHLBI) are available to share updates about research designed to support people living with rare or uncommon heart, lung, and blood conditions. WHY: In the U.S., a condition is considered rare if it affects less than 200...
|
News Release
Researchers have linked a rare genetic mutation found mostly in Black Americans and other people of African descent to an earlier onset of heart failure and a higher risk of hospitalization. The findings suggest that earlier screening for the mutation could lead to faster treatment and improved outcomes for heart failure in this vulnerable group...
|
News Release
A small clinical trial supported by the National Institutes of Health has found that eating during the nighttime—like many shift workers do—can increase glucose levels, while eating only during the daytime might prevent the higher glucose levels now linked with a nocturnal work life. The findings, the study authors said, could lead to novel...
|
Research Feature
For 33 years, the NHLBI’s Strong Heart Study has focused on learning why American Indians have one of the highest heart disease rates in the nation—almost double that of the general population. And during that time, it has made important discoveries – confirming, for example, that risk factors like diabetes, high blood pressure, and elevated...
|
Research Feature
For nearly 15 years, the Cardiothoracic Surgical Trials Network (CTSN) has played a key role in designing and conducting collaborative clinical trials aimed at improving surgical treatments for cardiovascular disease, the nation’s leading cause of death. CTSN’s efforts to learn more about these treatments – valve replacements, bypass procedures...
|
Research Feature
When Joia Crear-Perry, M.D., an obstetrician and gynecologist, found “African American descent” listed by cardiovascular experts as a risk factor for postpartum heart disease, she realized even advocates like her were doing something wrong, and that the media was amplifying the error. With the U.S. maternal health crisis gripping public attention –...